Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
L. Heaney (Belfast (Belfast), United Kingdom), F. Schleich (Liege, Belgium), S. Korn (Mainz, Germany), P. Howarth (London, United Kingdom), Z. Antoun (London, United Kingdom), A. Bourdin (Montpellier, France), G. Canonica (Milan, Italy). Recognising the long-term burden of short course oral corticosteroids. 3548

Member's Comments

No comment yet.

Related content which might interest you: How can we minimise the use of regular oral corticosteroids in asthma? Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019 Year: 2020 High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003 Comparison of the effect of short course of oral prednisone in patients with moderate and severe persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003 Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma Source: Eur Respir J 2002; 20: Suppl. 38, 8s Year: 2002 Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018 Year: 2018 Does a short course of oral glucocorticoids interfere with immune response in children with acute asthma? Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006 The effect of inhaled corticosteroids on the hypothalamic-pituitary-adrenal-axis in short term and long term treatment Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Does short-term treatment intensification influence long-term treatment effects on health status in COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 Modelling the beneficial impact of inhaled corticosteroids on health outcomes among COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Osteoporosis in patients with long-term inhaled corticosteroids treatment Source: Eur Respir J 2007; 30: Suppl. 51, 613s Year: 2007 Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE) Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Clinical benefits and safety of long term treatment with Montelukast in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 525s Year: 2002 The influence of high doses of N-acetylcysteine alone or in combination with inhaled corticosteroids on quality of life in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011 Short term oral corticosteroid trials in patients with unexplained chronic cough Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach Year: 2010 Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019